BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38781342)

  • 1. CK2-dependent degradation of CBX3 dictates replication fork stalling and PARP inhibitor sensitivity.
    Ma J; Ren D; Wang Z; Li W; Li L; Liu T; Ye Q; Lei Y; Jian Y; Ma B; Fan Y; Liu J; Gao Y; Jin X; Huang H; Li L
    Sci Adv; 2024 May; 10(21):eadk8908. PubMed ID: 38781342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylated RPA recruits PALB2 to stalled DNA replication forks to facilitate fork recovery.
    Murphy AK; Fitzgerald M; Ro T; Kim JH; Rabinowitsch AI; Chowdhury D; Schildkraut CL; Borowiec JA
    J Cell Biol; 2014 Aug; 206(4):493-507. PubMed ID: 25113031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High speed of fork progression induces DNA replication stress and genomic instability.
    Maya-Mendoza A; Moudry P; Merchut-Maya JM; Lee M; Strauss R; Bartek J
    Nature; 2018 Jul; 559(7713):279-284. PubMed ID: 29950726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RFWD3-Dependent Ubiquitination of RPA Regulates Repair at Stalled Replication Forks.
    Elia AE; Wang DC; Willis NA; Boardman AP; Hajdu I; Adeyemi RO; Lowry E; Gygi SP; Scully R; Elledge SJ
    Mol Cell; 2015 Oct; 60(2):280-93. PubMed ID: 26474068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-PKcs and PARP1 Bind to Unresected Stalled DNA Replication Forks Where They Recruit XRCC1 to Mediate Repair.
    Ying S; Chen Z; Medhurst AL; Neal JA; Bao Z; Mortusewicz O; McGouran J; Song X; Shen H; Hamdy FC; Kessler BM; Meek K; Helleday T
    Cancer Res; 2016 Mar; 76(5):1078-88. PubMed ID: 26603896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ADP-ribosyl)ation of TIMELESS limits DNA replication stress and promotes stalled fork protection.
    Rageul J; Lo N; Phi AL; Patel JA; Park JJ; Kim H
    Cell Rep; 2024 Mar; 43(3):113845. PubMed ID: 38393943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive RPA2 hyperphosphorylation promotes apoptosis in response to DNA replication stress in CHK1 inhibited cells.
    Zuazua-Villar P; Ganesh A; Phear G; Gagou ME; Meuth M
    Nucleic Acids Res; 2015 Nov; 43(20):9776-87. PubMed ID: 26271993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human RPA phosphorylation by ATR stimulates DNA synthesis and prevents ssDNA accumulation during DNA-replication stress.
    Vassin VM; Anantha RW; Sokolova E; Kanner S; Borowiec JA
    J Cell Sci; 2009 Nov; 122(Pt 22):4070-80. PubMed ID: 19843584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oncoprotein DEK affects the outcome of PARP1/2 inhibition during mild replication stress.
    Ganz M; Vogel C; Czada C; Jörke V; Gwosch EC; Kleiner R; Pierzynska-Mach A; Zanacchi FC; Diaspro A; Kappes F; Bürkle A; Ferrando-May E
    PLoS One; 2019; 14(8):e0213130. PubMed ID: 31408463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WRN helicase safeguards deprotected replication forks in BRCA2-mutated cancer cells.
    Datta A; Biswas K; Sommers JA; Thompson H; Awate S; Nicolae CM; Thakar T; Moldovan GL; Shoemaker RH; Sharan SK; Brosh RM
    Nat Commun; 2021 Nov; 12(1):6561. PubMed ID: 34772932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCAF-Mediated Histone Acetylation Promotes Replication Fork Degradation by MRE11 and EXO1 in BRCA-Deficient Cells.
    Kim JJ; Lee SY; Choi JH; Woo HG; Xhemalce B; Miller KM
    Mol Cell; 2020 Oct; 80(2):327-344.e8. PubMed ID: 32966758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSB and SMARCAL1 compete for RPA32 at stalled forks and differentially control the fate of stalled forks in BRCA2-deficient cells.
    Batenburg NL; Sowa DJ; Walker JR; Andres SN; Zhu XD
    Nucleic Acids Res; 2024 May; 52(9):5067-5087. PubMed ID: 38416570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E3 ligase RFWD3 is a novel modulator of stalled fork stability in BRCA2-deficient cells.
    Duan H; Mansour S; Reed R; Gillis MK; Parent B; Liu B; Sztupinszki Z; Birkbak N; Szallasi Z; Elia AEH; Garber JE; Pathania S
    J Cell Biol; 2020 Jun; 219(6):. PubMed ID: 32391871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMARCAL1 ubiquitylation controls its association with RPA-coated ssDNA and promotes replication fork stability.
    Yates M; Marois I; St-Hilaire E; Ronato DA; Djerir B; Brochu C; Morin T; Hammond-Martel I; Gezzar-Dandashi S; Casimir L; Drobetsky E; Cappadocia L; Masson JY; Wurtele H; Maréchal A
    PLoS Biol; 2024 Mar; 22(3):e3002552. PubMed ID: 38502677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCNA-mediated stabilization of E3 ligase RFWD3 at the replication fork is essential for DNA replication.
    Lin YC; Wang Y; Hsu R; Giri S; Wopat S; Arif MK; Chakraborty A; Prasanth KV; Prasanth SG
    Proc Natl Acad Sci U S A; 2018 Dec; 115(52):13282-13287. PubMed ID: 30530694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Rad52-dependent replication fork recovery through serine ADP-ribosylation of PolD3.
    Richards F; Llorca-Cardenosa MJ; Langton J; Buch-Larsen SC; Shamkhi NF; Sharma AB; Nielsen ML; Lakin ND
    Nat Commun; 2023 Jul; 14(1):4310. PubMed ID: 37463936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E3 ligase RFWD3 participates in replication checkpoint control.
    Gong Z; Chen J
    J Biol Chem; 2011 Jun; 286(25):22308-13. PubMed ID: 21504906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of RPA2 phosphorylation in homologous recombination in response to replication arrest.
    Shi W; Feng Z; Zhang J; Gonzalez-Suarez I; Vanderwaal RP; Wu X; Powell SN; Roti Roti JL; Gonzalo S; Zhang J
    Carcinogenesis; 2010 Jun; 31(6):994-1002. PubMed ID: 20130019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical interaction between replication protein A (RPA) and MRN: involvement of RPA2 phosphorylation and the N-terminus of RPA1.
    Oakley GG; Tillison K; Opiyo SA; Glanzer JG; Horn JM; Patrick SM
    Biochemistry; 2009 Aug; 48(31):7473-81. PubMed ID: 19586055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms for stalled replication fork stabilization: new targets for synthetic lethality strategies in cancer treatments.
    Liao H; Ji F; Helleday T; Ying S
    EMBO Rep; 2018 Sep; 19(9):. PubMed ID: 30108055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.